Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...

Dr. Jelena Kecmanovic is a clinical psychologist in the Washington, DC, area and an adjunct lecturer at Georgetown University. Her Substack is “No Delusions with Dr. K. Psychologist.” Spencer ...

Representative Mark Amodei of Nevada, a Republican, on Friday added his name to the list of dozens of Republicans who will not seek reelection in the 2026 midterms, bringing the total to 30 lawmakers ...

Abstract: In this paper, we address the bin packing problem while minimizing the total loading cost of used bins. We focus on two different quantity discount schemes: the all unit discount and the ...

A new program in Bettendorf will help homeowners fix their sewer lines. City council approved the sanitary sewer lateral assistance program February 3. These sewer systems connect homes and businesses ...

In January 2026, Microsoft Defender Experts identified a new evolution in the ongoing ClickFix campaign. This updated tactic deliberately crashes victims’ browsers and then attempts to lure users into ...

Abstract: The finite resources of automated guided vehicles (AGVs) and machines in a flexible manufacturing system necessitate the integrated scheduling of production and transportation tasks to ...

Biodiversity loss is continuing at an unprecedented rate, with species becoming extinct at between 100 and 1,000 times the average pre-human, or ‘background’, rate. Human activities are the main cause ...

HOUSTON, Texas (KTRK) -- The federal government has ordered Houston housing officials to explain how they plan to fix the city's affordable housing program. The agency has come under fire for years, ...

The Seattle Seahawks have to focus on the task at hand. They're one win away from glory, and that should be the only thing on their minds right now. At least, that applies to the players and the ...

A key Florida program providing healthcare for children with birth-related neurological injuries is facing a funding shortfall. Proposed legislation aims to make the program solvent but faces ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.